Plus: Strong efficacy data emerge for maternal RSV vaccination and a rare 22-week uterine rupture is successfully repaired, and UNICEF launches Femtech Ventures.
A federal appeals court temporarily blocked the ability to obtain mifepristone orders by mail, reinstating a nationwide requirement for in-person access. This decision impacts access to reproductive healthcare and may reshape how femtech intersects with regulatory policy. Concurrent developments include new data on maternal health interventions and a significant investment in femtech startups across Africa and Asia. These stories collectively highlight both the ongoing political and clinical challenges, and the investment opportunities within women's health. Five takes inside, plus a quick-hits roundup.
VIA FemTech Insider
UNICEF has launched UNICEF Femtech Ventures, a five-year catalytic investment platform backed by the Government of Sweden and Temasek Foundation. The first cohort includes eleven frontier tech startups from Africa and Asia, selected from over 1,100 applications across 85 countries, each receiving up to $100,000 in equity-free capital and a year of technical assistance.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
A federal appeals court temporarily blocked the ability to obtain mifepristone orders by mail. The court reinstated a nationwide requirement for abortion pills to be obtained in person.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
Infants receiving preventive RSV measures, including maternal vaccination, demonstrated significantly lower rates of RSV infection. These findings were presented at the Pediatric Academic Societies meeting.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
Off-label prescribing of HSDD medications is common in postmenopausal women, highlighting unmet treatment needs. There is also a gap between patient search behavior and clinical terminology for these medications in this population.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
A rare uterine rupture at 22 weeks of pregnancy was successfully repaired. This intervention allowed the pregnancy to continue, resulting in a successful delivery at 32 weeks.
Read the full story →
— The Luteal Editorial Team